Altimmune's total assets for Q2 2025 were $190.35M, an increase of 21.04% from the previous quarter. ALT total liabilities were $28.98M for the fiscal quarter, a 91.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.